Sinusave
About this raise
SinuSave, a drug-free nasal congestion solution, is raising funds on Razitall. It is the only patented all-natural solution for a daily nasal wash to keep the sinuses clean. Sinusave is safe for all age groups above three and is saline-free. It can be marketed over-the-counter in pharmacies, health stores, supermarket pharmacies, wellness product catalogs, and online. Sinusave was founded by Paul A. Lobel, with decades of experience in sales and marketing and research & development. The current crowdfunding round has a target raise of $537,000, and the proceeds will be used for advertising, payment of salaries, expansion of product catalog, and beefing up of point of sales assets at independent health stores. Sinusave formulations have been in production since March 2018, and they are manufactured in an FDA-certified facility.
Investment Overview
Not Funded: $0
Deal Terms
Company & Team
Company
- Year Founded
- 2018
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B/B2C
- Margin
- High
- Capital Intensity
- Low
Financials
-
Revenue
- $19,793
- Monthly Burn
- $19,200
-
Runway
- 0.4 months
- Gross Margin
- 1%
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
---|---|---|---|---|---|---|
06/09/2020 | Razitall | $3,977,777 | $0 | CAFES | Not Funded | RegCF |